Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users

Journal of Infectious Diseases

Volumn 173, Issue 3, 1996, Pages 579-583

  Levine, Orin S ^a,c   Vlahov, David ^a,b   Brookmeyer, Ron ^a   Cohn, Sylvia ^a   Nelson, Kenrad E ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Centers for Dis Contr and Prev ^*  (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION; STATISTICAL ANALYSIS; VIRUS TRANSMISSION;

EID: 0030041774     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.3.579     Document Type: Article

References (21)

1. Vlahov D, Brookmeyer RS. The evaluation of needle exchange programs. Am J Public Health 1994;84:1889-90.
2. Des Jarlais DC, Friedman SR. HIV infection among intravenous drug users: epidemiology and risk reduction. AIDS 1987; 1:67-76.
3. Vlahov D. HIV seroconversion studies among intravenous drug users. AIDS 1994;8:263-5.
4. Vlahov D, Polk BF. Perspectives on infection with HIV-1 among intravenous drug users [review]. Psychopharmacol Bull 1988;24:325-9.
5. Centers for Disease Control. Acquired immunodeficiency syndrome (AIDS): precautions for clinical and laboratory staffs. MMWR Morb Mortal Wkly Rep 1982;31:557-60.
6. Hagan H, Reid T, Des Jarlais DC, Purchase D, Friedman SR, Bell TA. The incidence of HBV infection and syringe exchange programs. JAMA 1991;266:1646-7.
7. Hagan H, Des Jarlais DC, Friedman SR, Purchase D, Alter MJ. Reduced risk of hepatitis B and hepatitis C among injecting drug users participating in the Tacoma syringe exchange program. Am J Public Health 1995;85:1531-7.
8. Lanphear BP. Trends and patterns in the transmission of bloodborne pathogens to health care workers. Epidemiol Rev 1994; 16:437-50.
9. Hoofnagle JH, Schafer DF. Serologic markers of hepatitis B virus infection [review]. Semin Liver Dis 1986;6:1-10.
10. Levine OS, Vlahov D, Nelson KE. Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors, and viral interactions. Epidemiol Rev 1994; 16:418-36.
11. van Haastrecht HJ, van den Hoek JA, Bardoux C, Leentvaar-Kuypers A, Coutinho RA. The course of the HIV epidemic among intravenous drug users in Amsterdam, The Netherlands. Am J Public Health 1991; 81:59-62.
12. Mele A, Rezza G, Stazi MA, Gill ON, Pasquini P. Incidence of acute hepatitis B in injecting drug users as an indicator of continuing HIV transmission - international implications [letter]. AIDS 1990;4:598-9.
13. Chamot E, de Saussure P, Hirschel B, Deglon JJ, Perrin LH. Incidence of hepatitis C, hepatitis B, and HIV infections among drug users in a methadone-maintenance programme [letter]. AIDS 1992;6:430-1.
14. Vlahov D, Anthony JC, Mun̄oz A, et al. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr 1991; 109:75-100.
15. Levine OS, Vlahov DA, Koehler J, Cohn S, Spronk AM, Nelson KE. Seroepidemiology of hepatitis B virus in a population of injecting drug users: association with drug injection patterns. Am J Epidemiol 1994; 142:331-41.
16. Kahn HA, Sempos CT. Statistical methods in epidemiology. New York: Oxford University Press, 1989:1.
17. Breslow NE, Day NE. Statistical methods in cancer research. Vol 1. The analysis of cohort studies. New York: Oxford University Press, 1987.
18. Vlahov D, Mun̄oz A, Anthony JC, Cohn S, Celentano DD, Nelson KE. Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am J Epidemiol 1990; 132:847-56.
19. Solomon L, Astemborski J, Warren D, et al. Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users. Am J Epidemiol 1993; 137:892-8.
20. Nicolosi A, Correa Leite ML, Musicco M, Molinari S, Lazzarin A, Northern Italian Seronegative Drug Addicts Study. Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. Am J Epidemiol 1992; 135:225-33.
21. Nelson KE, Vlahov D, Mun̄oz A, Cohn S, Solomon L. Incidence of HIV-1 infections in a cohort of intravenous drug users. Arch Intern Med 1995;155:1305-11.